Home Cart Sign in  
Chemical Structure| 425399-05-9 Chemical Structure| 425399-05-9

Structure of CASIN
CAS No.: 425399-05-9

Chemical Structure| 425399-05-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CASIN is an inhibitor of GTPase Cdc42 with IC50 of 2 μM that can generat a rejuvenated phenotype of HSCs.

Synonyms: CASIN

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CASIN

CAS No. :425399-05-9
Formula : C20H22N2O
M.W : 306.40
SMILES Code : OCCNC1C2=C(C3=C(N2)C=CC(C4=CC=CC=C4)=C3)CCC1
Synonyms :
CASIN
MDL No. :MFCD01853271
InChI Key :RXIUMAOXORBRCY-UHFFFAOYSA-N
Pubchem ID :2882155

Safety of CASIN

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CASIN

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
skeletal muscle stem cells (MuSCs) 0.5-5 µM 24-48 h reduced Cdc42 activity, increased divisional kinetics and myogenic colony capacity NPJ Regen Med. 2022 Dec 29;7(1):78
CD4+ T cells 10 μM 4 days To evaluate the effect of CASIN on Th2 cell differentiation, results showed that CASIN selectively inhibited Th2 cell differentiation. Clin Exp Allergy. 2019 Jan;49(1):92-107
hematopoietic stem cells 5 µM 16 h Reduced Cdc42 activity in aged cells to the level found in young cells resulted in long-lasting youthful function of HSCs in vivo, likely due to epigenetic remodeling of aged cells upon modulation of Cdc42 activity Aging Cell. 2020 Sep;19(9):e13208
primary fibroblasts 0.5 μM 24 h Promoted cell proliferation and collagen synthesis, restored cytoskeletal morphology, and exhibited anti-aging effects Aging Cell. 2024 Dec;23(12):e14333
primary keratinocytes 0.5 μM 24 h Enhanced cell proliferation, restored cytoskeletal morphology, and exhibited anti-aging effects Aging Cell. 2024 Dec;23(12):e14333
long-term hematopoietic stem cells (LT-HSCs) indicated concentrations 16 h CASIN inhibited SDF-1α-induced F-actin polymerization. Leukemia. 2019 Mar;33(3):749-761
Lin−Kit+ progenitors increasing concentrations CASIN affected the polarized distributions of endogenous Cdc42 and Tubulin. Leukemia. 2019 Mar;33(3):749-761
low-density bone marrow (LDBM) cells 5 μM 15 min CASIN suppressed Cdc42-GTP formation activated by SCF, SDF-1α, or fibronectin but did not affect Rac1 activity. Leukemia. 2019 Mar;33(3):749-761

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Aged immunocompromised mice Intraperitoneal injection 25 mg/kg 4 consecutive days, every 24 hours Improved locomotor activity, endurance, and grip strength, extended lifespan NPJ Regen Med. 2022 Dec 29;7(1):78
Mice OVA-induced allergic airway inflammation model Intraperitoneal injection 30 mg/kg Daily starting one day before OV A immunization until one day before sacrifice To evaluate the preventive effect of CASIN on allergic airway inflammation, results showed that CASIN significantly alleviated allergic airway inflammation. Clin Exp Allergy. 2019 Jan;49(1):92-107
C57BL/6 mice 75-week-old female mice Intraperitoneal injection 25 mg/kg 4 consecutive days, every 24 hours Short-term systemic reduction of Cdc42 activity significantly extended average and maximum lifespan, reduced levels of aging-associated cytokines IL-1β, IL-1α, and INFγ, and showed a younger epigenetic clock based on DNA methylation levels in blood cells Aging Cell. 2020 Sep;19(9):e13208
C57BL/6 female mice Naturally aging mouse model Subcutaneous injection 1 μg 6 consecutive days, once daily Increased epidermal and dermal thickness, enhanced dermal-epidermal junction, stimulated collagen and elastic fiber synthesis, and exhibited anti-aging effects Aging Cell. 2024 Dec;23(12):e14333
C57Bl/6 mice HSC mobilization model Intravenous (IV) injection 1.2 mg/kg Single injection, analyzed at 2 h CASIN transiently mobilized HSCs from BM to PB by inhibiting Cdc42 activity, and the mobilized HSCs exhibited better long-term reconstitution potential. Leukemia. 2019 Mar;33(3):749-761

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.26mL

0.65mL

0.33mL

16.32mL

3.26mL

1.63mL

32.64mL

6.53mL

3.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories